李永乐 数学讲师
广受学生信赖的“线代王”- 预约
厦门大学生物制品学专业研究生导师冯根生介绍 English Introduction
怎么找到复试导师的联系方式，应该选择什么样的方式呢?在实际联系导师的过程中，大家使用的方式无非是以下几种：邮件、电话、面谈。老师的邮箱在「学院官网」——「师资力量」——「任职教师」——「导师介绍」，这个路径就能找到。
| 姓 名 | 冯根生 | 性 别 | 男 | 出生年月 | 1961-09 |
|---|---|---|---|---|---|
| 所在院校 | 厦门大学 | 所在院系 | 生物医学研究院 | ||
| 职称 | 教授 | 招生专业 | 化学生物学 | ||
| 研究领域 | 探讨糖尿病与肥胖症的分子机理及新型药物的开发 |
| 联系方式 | gfeng@burnham.org | 电 话 | 0592******* | 邮 编 | 361005 | |
|---|---|---|---|---|---|---|
| 地 址 | 福建省厦门市厦门大学生物医学研究院 |
| 个人简介 |
| 冯根生教授、博导，1981年毕业于中国杭州大学生物学系，1982年－1984年就读于第二军医大学，获免疫学硕士，1990年获印第安那大学分子生物学博士学位。现任加州Burnham研究所教授，兼加州大学圣地亚哥分校病理系教授，2006年聘为厦门大学生物医学研究院兼职教授，同年评为博士生导师。 研究方向为探讨糖尿病与肥胖症的分子机理及新型药物的开发，得到美国国立卫生研究院（NIH）的支持。先后获得11项研究基金，共计500万美元。 1999年获中国国家杰出青年科学基金。先后在Science、Nature Medicine、PNAS、EMBO J. 等国际著名学术刊物发表了60多篇文章，并应邀为Trends In Genetics写综述充分证明他在其所在领域中的学术地位。担任Nature Cell Biology等十个国际著名学术刊物的Reviewer。 应邀做过七十多个学术报告，并为美国、欧洲、香港的八个基金机构包括美国国立卫生研究院、美国心脏学会、美国癌症学会等担任评审人，同时被浙江大学聘为“光彪”讲座教授。冯根生博士在细胞信号传导及糖尿病与肥胖症的机理研究方面做出了世界领先的突出贡献，被吴瑞先生列为1949年以来对生物化学领域做出突出贡献的84位旅美华人科学家之一。 冯根生教授、博导，1981年毕业于中国杭州大学生物学系，1982年－1984年就读于第二军医大学，获免疫学硕士，1990年获印第安那大学分子生物学博士学位。现任加州Burnham研究所教授，兼加州大学圣地亚哥分校病理系教授，2006年聘为厦门大学生物医学研究院兼职教授，同年评为博士生导师。 研究方向为探讨糖尿病与肥胖症的分子机理及新型药物的开发，得到美国国立卫生研究院（NIH）的支持。先后获得11项研究基金，共计500万美元。 1999年获中国国家杰出青年科学基金。先后在Science、Nature Medicine、PNAS、EMBO J. 等国际著名学术刊物发表了60多篇文章，并应邀为Trends In Genetics写综述充分证明他在其所在领域中的学术地位。担任Nature Cell Biology等十个国际著名学术刊物的Reviewer。 应邀做过七十多个学术报告，并为美国、欧洲、香港的八个基金机构包括美国国立卫生研究院、美国心脏学会、美国癌症学会等担任评审人，同时被浙江大学聘为“光彪”讲座教授。冯根生博士在细胞信号传导及糖尿病与肥胖症的机理研究方面做出了世界领先的突出贡献，被吴瑞先生列为1949年以来对生物化学领域做出突出贡献的84位旅美华人科学家之一。 |
| 著作及论文 |
| 论文发表： (1) PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase ，《BLOOD》，2007年02月 (2) SHP-2 phosphatase negatively regulates the TRIF adaptor protein-dependent type I interferon and proinflammatory cytokine production ，《IMMUNITY》，2006年12月 (3) Concerted functions of Gab1 and Shp2 in liver regeneration and hepatoprotection ，《MOLECULAR AND CELLULAR BIOLOGY 》，2006年06月 (4) Overexpression of Shp2 tyrosine phosphatase is implicated in leukemogenesis in adult human leukemia ，《BLOOD》，2005年11月 (5) Deletion of Gab1 in the liver leads to enhanced glucose tolerance and improved hepatic insulin action ，《NATURE MEDICINE 》，2005年05月 (6) Mutated SHP and AML in leukemias ，《 BLOOD 》，2004年03月 (7) Role of Gab1 in UV-induced c-Jun NH2-terminal kinase activation and cell apoptosis ，《MOLECULAR AND CELLULAR BIOLOGY 》，2004年02月 (8) Force-dependent integrin-cytoskeleton linkage formation requires downregulation of focal complex dynamics by Shp2 ，《EMBO JOURNAL 》，2003年10月 (9) SH2 domain containing protein tyrosine phosphatase 2 regulates concanavalin A-dependent secretion and activation of matrix metalloproteinase 2 via the extracellular signal-regulated kinase and p38 pathways ，《CANCER RESEARCH 》，2003年10月 (10) A definitive role of Shp-2 tyrosine phosphatase in mediating embryonic stem cell differentiation and hematopoiesis ，《BLOOD》，2003年09月 (11) Requirement of Shp-2 tyrosine phosphatase in lymphoid and hematopoietic cell development ，《BLOOD》，2001年02月 论文发表： (1) PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase ，《BLOOD》，2007年02月 (2) SHP-2 phosphatase negatively regulates the TRIF adaptor protein-dependent type I interferon and proinflammatory cytokine production ，《IMMUNITY》，2006年12月 (3) Concerted functions of Gab1 and Shp2 in liver regeneration and hepatoprotection ，《MOLECULAR AND CELLULAR BIOLOGY 》，2006年06月 (4) Overexpression of Shp2 tyrosine phosphatase is implicated in leukemogenesis in adult human leukemia ，《BLOOD》，2005年11月 (5) Deletion of Gab1 in the liver leads to enhanced glucose tolerance and improved hepatic insulin action ，《NATURE MEDICINE 》，2005年05月 (6) Mutated SHP and AML in leukemias ，《 BLOOD 》，2004年03月 (7) Role of Gab1 in UV-induced c-Jun NH2-terminal kinase activation and cell apoptosis ，《MOLECULAR AND CELLULAR BIOLOGY 》，2004年02月 (8) Force-dependent integrin-cytoskeleton linkage formation requires downregulation of focal complex dynamics by Shp2 ，《EMBO JOURNAL 》，2003年10月 (9) SH2 domain containing protein tyrosine phosphatase 2 regulates concanavalin A-dependent secretion and activation of matrix metalloproteinase 2 via the extracellular signal-regulated kinase and p38 pathways ，《CANCER RESEARCH 》，2003年10月 (10) A definitive role of Shp-2 tyrosine phosphatase in mediating embryonic stem cell differentiation and hematopoiesis ，《BLOOD》，2003年09月 (11) Requirement of Shp-2 tyrosine phosphatase in lymphoid and hematopoietic cell development ，《BLOOD》，2001年02月 |
English Introduction
Prof. Feng Gensheng graduated from the Department of Biology, Hangzhou University, China in 1981. From 1982 to 1984, he received a master's degree in immunology from the Second Military Medical University. In 1990, he received a doctor's degree in molecular biology from Indiana University. He is currently a professor at the Burnham Research Institute of California and a professor at the Department of Pathology at the University of California, San Diego. He was appointed as an adjunct professor at the Institute of Biomedical Sciences of Xiamen University in 2006 and was named doctoral supervisor in the same year.
The research is supported by the National Institutes of Health (NIH) to explore the molecular mechanism of diabetes and obesity and to develop novel drugs. It has received 11 research grants totaling 5 million US dollars.
In 1999, he was awarded the National Science Foundation for Outstanding Young People of China. He successively studied in Science, Nature Medicine, PNAS, EMBO J. He has published more than 60 articles In international famous academic journals, and was invited to write a review on Trends In Genetics, which fully demonstrates his academic status in his field. Served as a Reviewer of 10 internationally renowned academic journals such as Nature Cell Biology.
He was invited to give more than 70 academic reports, and served as a reviewer for eight foundation organizations in the United States, Europe and Hong Kong, including the National Institutes of Health, the American Heart Association, the American Cancer Society, and so on. At the same time, he was appointed as the "Guangbiao" Professor in Zhejiang University. Dr. Feng Gensheng has made outstanding contributions to the research of cell signaling and the mechanism of diabetes and obesity. He is listed as one of the 84 Chinese scientists in the United States who have made outstanding contributions to the field of biochemistry since 1949 by Mr. Wu Rui.
Prof. Feng Gensheng graduated from the Department of Biology, Hangzhou University, China in 1981. From 1982 to 1984, he received a master's degree in immunology from the Second Military Medical University. In 1990, he received a doctor's degree in molecular biology from Indiana University. He is currently a professor at the Burnham Research Institute of California and a professor at the Department of Pathology at the University of California, San Diego. He was appointed as an adjunct professor at the Institute of Biomedical Sciences of Xiamen University in 2006 and was named doctoral supervisor in the same year.
